10 Most Profitable Biotech Stocks to Invest in Now

2. Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)

TTM Net Income: $4.5 billion

Number of Hedge Fund Holders: 66

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is one of the most profitable biotech stocks to invest in now. Canaccord updated estimates on Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) on July 24, reiterating a Buy rating on the stock with an $850 price target.

The firm stated that it anticipates weakness to continue in EYLEA sales for Q2 2025, primarily because of biosimilar competition and continued co-pay assistance shortfalls.

Canaccord further said that it is on the lookout for updates from the pipeline (Factor XI, Obesity) to point to potential upside in the second half of 2025.

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is a biotechnology company that develops, discovers, and commercializes therapies for several diseases, including cancer, eye disorders, and allergic conditions.